DocMorris AGXSWX:DOCM +1.65%65 Equity-to-Asset is 0.53 as of Jun. 2025, which is 26% above its 10-year median of 0.42. GuruFocus rates XSWX:DOCM with a GF Score™ of 65/100 and a GF Value™ of CHF10.56 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 685 Healthcare Providers & Services companies, DocMorris AG ranks better than 53.87% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. DocMorris AG's Total Stockholders Equity for the quarter that ended in Jun. 2025 was CHF480 Mil. DocMorris AG's Total Assets for the quarter that ended in Jun. 2025 was CHF907 Mil.
Therefore, DocMorris AG's Equity to Asset Ratio for the quarter that ended in Jun. 2025 was 0.53.
The historical rank and industry rank for DocMorris AG's Equity-to-Asset or its related term are showing as below:
XSWX:DOCM'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31 Med: 0.42 Max: 0.64
Current: 0.53
During the past 13 years, the highest Equity to Asset Ratio of DocMorris AG was 0.64. The lowest was 0.31. And the median was 0.42.
XSWX:DOCM's Equity-to-Asset is ranked better than 53.87% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 0.5
vs XSWX:DOCM: 0.53
DocMorris AG (XSWX:DOCM) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
DocMorris AG Equity-to-Asset Related Terms
DocMorris AG Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for DocMorris AG's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG Equity-to-Asset Competitor Comparison
For the Pharmaceutical Retailers subindustry, DocMorris AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where DocMorris AG's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
DocMorris AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG (XSWX:DOCM) has a Equity-to-Asset of 0.53 as of Jun. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on DocMorris AG and its competitors. This is 26% above median its historical median of 0.42. Over the past decade, DocMorris AG's Equity-to-Asset has ranged from 0.31 to 0.64. According to the industry distribution chart, DocMorris AG ranks #316 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 46.1%.
Is DocMorris AG's Equity-to-Asset too high?
DocMorris AG's current Equity-to-Asset of 0.53 is 26% above median its 10-year median of 0.42. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 0.64. The Healthcare Providers & Services industry median Equity-to-Asset is 0.50. DocMorris AG's value of 0.53 is 6% above this industry median. Based on the distribution chart, DocMorris AG ranks #316 out of 685 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Equity-to-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #316 out of 685 companies for Equity-to-Asset. This puts DocMorris AG in the upper half of its industry. The industry median Equity-to-Asset is 0.50. DocMorris AG's value of 0.53 is 6% above this benchmark. Historically, DocMorris AG's own Equity-to-Asset has ranged from 0.31 to 0.64 over the past decade. While the company's 10-year median is 0.42 vs. the industry median of 0.50, DocMorris AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.50, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocMorris AG's current Equity-to-Asset of 0.53 is 6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on DocMorris AG and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current Equity-to-Asset is 0.53, which is 26% above median its own 10-year median of 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.56, compared to a current price of CHF9.25 — trading 12.4% below its estimated fair value. The current Equity-to-Asset is 0.53, which is 26% above median its 10-year median of 0.42 and 6% above the Healthcare Providers & Services industry median of 0.50. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current Equity-to-Asset is 0.53 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF9.25 is trading 12.4% below its estimated GF Value™ of CHF10.56.
GuruFocus considers DocMorris AG to be Modestly Undervalued.
Key valuation signals for XSWX:DOCM:
Equity-to-Asset: 0.53 (26% above median its 10-year median of 0.42)
GF Value™: CHF10.56 vs. price of CHF9.25 (12.4% below fair value)
Industry Position: 6% above the Healthcare Providers & Services median (#316 of 685)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 
